Argenx to buy Forte Biosciences for about $2.2 billion
argenxargenx(US:ARGX) Reuters·2026-07-27 13:15

收购交易 - 比利时-荷兰免疫学公司argenx将收购Forte Biosciences [1] - 此次收购旨在将实验性自身免疫药物FB102纳入其产品组合 [1] 收购标的与资产 - 收购标的为Forte Biosciences公司 [1] - 核心收购资产为实验性自身免疫药物FB102 [1]

argenx-Argenx to buy Forte Biosciences for about $2.2 billion - Reportify